CBIC orders vigilance probe into alleged irregularities at Chennai customs in Wintrack case https://t.co/uY74eusVUN #CBIC #Chennai #Customs @TimsyJaipuria

India’s gifting economy becomes a key driver of festive consumption @TimsyJaipuria https://t.co/kfTjaNZI3w

#WorldMentalHealthDay2025 | From children to seniors, India’s #mentalhealth journey reflects rising awareness and urgency, with early intervention, digital outreach & community care shaping a more resilient and compassionate society By @TimsyJaipuria https://t.co/iWXPqDcU5a

.@NITIAayog urges decriminalising minor offences under the new #IncomeTaxAct, 2025, advocating a shift from punitive enforcement to a trust-based system, with criminal action limited to serious tax fraud @TimsyJaipuria reports https://t.co/B6qrcAAibB

The @CDSCO_INDIA_INF begins review of India’s new drug approval framework, seeking stakeholder input to fix gaps between first movers and later entrants, in a move set to reshape the ₹3.4 lakh crore pharma industry. @TimsyJaipuria reports https://t.co/XQEzwxWuRw

India's Central Drug Safety Regulator begins a pan-India drive to test and audit all cough syrup makers, say sources. This comes after 22 children died in Madhya Pradesh after consuming potentially toxic cough syrups. @TimsyJaipuria reports

#CoughSyrupDeaths | In a startling revelation, the @CDSCO_INDIA_INF was unaware that a company named #SresanPharma existed in the country until contaminated cough syrup samples linked to the firm tested positive for dangerously high levels of #DiethyleneGlycol By:

The @CDSCO_INDIA_INF launches nationwide audit of #coughsyrup manufacturers after toxic syrup incidents, directing states & UTs to submit detailed lists to ensure compliance & strengthen drug safety standards, sources to @TimsyJaipuria #CoughSyrupDeaths

#CDSCO unaware of Sresan Pharma: Toxic syrup case unravels regulatory gaps @TimsyJaipuria https://t.co/ShLnyxgWEb

#CoughSyrupDeaths: Sources To CNBC-TV18 ▶️CDSCO begins pan india drive to test, inspect & audit all cough syrup manufacturers ▶️CDSCO seeks detailed list from all states/UTs of all cough syrup manufacturers ▶️State FDA & CDSCO teams to do joint inspection Alert: In 2023,

#JustIn | DCGI writes to All State/ UT Drug Controllers #DCGI Says; In light of child death reports in Madhya Pradesh, DCGI stresses strict adherence to Drug Rules. Noted lapses include failure by manufacturers to test each API batch for compliance before drug production.

DCGI @CDSCO_INDIA_INF writes to All State/UT Drug Controllers: Emphasizes on Strict compliance with the Drugs Rules, 1945, for testing of raw materials & finished formulations Writes in the backdrop of reports of alleged #CoughSyrupDeaths in Chhindwara, Madhya Pradesh, &

GST on hotel rooms under ₹7,500 was cut from 12% to 5% but prices have not dropped for customers . @TimsyJaipuria explains why. #GST

Navi Mumbai real estate gets wings as PM inaugurates ₹19,650 crore airport @TimsyJaipuria https://t.co/56HmRXNL5w

Drug Controller recommends Sresan Pharma's licence cancellation after high DEG levels found in cough syrups @TimsyJaipuria https://t.co/Fi1kys3lkN

Madhya Pradesh drug authorities ban 2 more cough syrup brands. 15 children have died so far after consuming toxic cough syrups. @TimsyJaipuria reports.

Festive retail takes off as tax cuts fuel consumer confidence @TimsyJaipuria https://t.co/LWYCj4kiw6

boAt’s turnaround: ₹60 crore profit, ₹3,000 crore revenue in FY25 @TimsyJaipuria https://t.co/MTGRiR3vmH

The festive season of 2025 begins on a strong note. Malls across Delhi-NCR report higher footfalls and stronger consumer spending. @TimsyJaipuria reports that the optimism is driven not just by festive spirit but by greater spending power. #Delhi #FestiveSeason2025 #CNBCTV18

🚨 BREAKING NEWS with @CNBCTV18Live Sources say: @MoHFW_INDIA Secretary Chairs High-Level Meeting with States/UTs on Quality & Rational Use of #CoughSyrup Emphasizes strict compliance with Revised Schedule M by all drug manufacturers; Reiterates that licences of non-compliant